Inogen Inc Cash Flow Statement
INGN|12 years of annual SEC 10-K data (FY2014-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 12 fiscal years. All figures from audited SEC 10-K filings.
Inogen Inc used $3M in operating cash flow and negative free cash flow of $8M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$102.4M | -$83.8M | -$6.3M | -$5.8M | $20.9M | $51.8M | $21.0M | $20.5M | $11.6M | $6.8M | $25.4M | $564.0K |
| Depreciation & Amortization | $18.2M | $23.5M | $21.6M | $18.6M | $13.8M | $11.3M | $12.3M | $13.6M | $14.0M | $12.1M | $8.5M | $5.0M |
| Operating Cash Flow | -$3.2M | -$37.5M | $23.6M | $37.0M | $40.6M | $60.0M | $60.5M | $31.0M | $38.2M | $15.7M | $13.5M | $4.0M |
| Capital Expenditures | $5.2M | $3.3M | $5.5M | $4.4M | $3.1M | $8.0M | $2.9M | $1.7M | $2.2M | $1.6M | $3.0M | $2.0M |
| Free Cash Flow | -$8.5M | -$40.9M | $18.2M | $32.6M | $37.5M | $51.9M | $57.6M | $29.3M | $36.0M | $14.1M | $10.4M | $2.0M |
| FCF Margin | -2.7% | -10.8% | 5.1% | 10.6% | 10.3% | 14.5% | 23.1% | 14.4% | 22.6% | 12.6% | 13.8% | 4.1% |